Reduced brain oxygen response to spreading depolarization predicts worse outcome in ischaemic stroke
Nils Hecht,Daisy Haddad,Konrad Neumann,Leonie Schumm,Nora F Dengler,Lars Wessels,Patrick Dömer,Simeon Helgers,Franziska Meinert,Sebastian Major,Coline L Lemale,Jens P Dreier,Peter Vajkoczy,Johannes Woitzik
DOI: https://doi.org/10.1093/brain/awae376
IF: 14.5
2024-11-24
Brain
Abstract:Spreading depolarization (SD) describes a propagating neuronal mass depolarization within the cerebral cortex that represents a mediator of infarct development and strongly stimulates the metabolic rate of O 2 consumption. Here, we investigated the influence of Spreading Depolarization (SD) on brain tissue partial pressure of O 2 (ptiO 2 ) within the peri-infarct tissue of patients suffering malignant hemispheric stroke (MHS). This prospective observational trial included 25 patients with MHS that underwent decompressive hemicraniectomy followed by subdural placement of electrodes for electrocorticography (ECoG) and neighboring implantation of a ptiO 2 probe within the peri-infarcted cortex. Continuous side-by-side ECoG + ptiO 2 recordings were obtained for 3-6 days postoperatively and analyzed for the occurrence of SD-independent and SD-coupled ptiO 2 changes, radiological findings, as well as their association with clinical outcome at 6 months. During the combined ECoG + ptiO 2 monitoring period of 2,604 hours and among 1,022 SDs, 483 (47%) SD-coupled ptiO 2 variations were identified as biphasic (59%), hypoxic (36%) or hyperoxic (5%) ptiO 2 responses that differed significantly (*p<0.0001). Among the remaining 538/1,022 (53%) SDs, no SD-coupled ptiO 2 response was detected, which we categorized as 'No response'. The overall infarct progression was 1.7% (IQR -2.5–10.9). Spreading Depolarization characteristics regarding type, duration and frequency, as well as SD-independent baseline ptiO 2 had no association with outcome. In contrast, a high occurrence rate and amplitude of SD-coupled variations in ptiO 2 were associated with improved outcome at 6 months (occurrence: r=-0.62, *p=0.035; amplitude: r=-0.57, *p=0.024; Spearman correlation). In conclusion, an absent or reduced ptiO 2 response to SD could indicate tissue-at-risk and help direct targeted treatment strategies in ischemic stroke, which is further evidence that not all SDs are the same, but that tissue responses coupled to SD such as ptiO 2 contain prognostic information. In particular, a lack of SD-coupled ptiO 2 variations appears to be a predictor of worse outcome in large hemispheric stroke.
neurosciences,clinical neurology